Overview
Carbon monoxide (CO) is a colorless, odorless, and tasteless gas that has a slightly lower density than air. It is toxic to hemoglobin utilizing animals (including humans), when encountered in concentrations above about 35 ppm, although it is also formed in normal animal metabolism in low quantities, and is thought to have some normal biological/homeostatic functions . Carbon monoxide (CO), is a ubiquitous environmental product of organic combustion, which is also formed endogenously in the human body, as the byproduct of heme metabolism . Exhaled CO (eCO), similar to exhaled nitric oxide (eNO), has been evaluated as a candidate breath biomarker of pathophysiological states, including smoking status, and inflammatory diseases of the lung and other organs. Exhalation of corbon monoxide values have been studied as potential indicators of inflammation in asthma, stable COPD and exacerbations, cystic fibrosis, lung cancer, and during surgery or critical care . A test of the diffusing capacity of the lungs for carbon monoxide (DLCO), is one of the most clinically valuable tests of lung function testing. The technique was first described 100 years ago, and applied to clinical practice many years after. The DLCO measures the ability of the lungs to transfer gas from inhaled air to the red blood cells in pulmonary capillaries. The DLCO test is both convenient and simple for the patient to undergo. The ten seconds of breath-holding required for the DLCO maneuver is easier for most patients to perform than the forced exhalation required for other respiratory tests . Carbon monoxide is presently used in small amounts in low oxygen modified atmosphere packaging systems (MAP) for fresh meat to stabilize and maintain natural meat color. This use of CO has been generally recognized as safe (GRAS) in several packaging applications for fresh meat products. Since 2002, FDA has favorably reviewed three GRAS notifications for carbon monoxide use in fresh meat packaging . The FDA classifies this drug as permitted as a food additive in the packaging and preparation of food products, while following the federal code of regulations . There have been several concerns voiced of over the use of carbon monoxide in food products , , . The European Union has banned the use of carbon monoxide as a color stabilizer in meat and fish. A December 2001 report from the European Commission's Scientific Committee on Food concluded that the gas did not pose a risk provided that food was maintained adequately cold during storage and transport to prevent the growth of microorganisms . In New Zealand, the use of carbon monoxide in fish preparation has been banned, as it may mask the effects of food spoilage and bacterial growth .
Indication
Used as a marker of respiratory status in spirometry tests , . Food additive for pigment fixation in meat .
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2024/04/02 | Early Phase 1 | Recruiting | |||
2017/03/01 | Phase 1 | Completed | |||
2012/02/01 | Phase 1 | Withdrawn | |||
2009/07/16 | Phase 3 | UNKNOWN | |||
2005/07/22 | Phase 2 | Completed | Groningen Research Institute for Asthma and COPD | ||
2004/10/18 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
King Bio Inc. | 57955-9001 | ORAL | 10 [hp_X] in 59 mL | 5/19/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
LUNG DIFFUSION TEST MIXTURE | matheson gas products canada inc. | 00580759 | Gas - Inhalation | .5 % | 12/31/1982 |
LUNG DIFFUSION TEST MIX NOHCO | liquid carbonic inc. | 00588067 | Gas - Inhalation | .3 % | 12/31/1968 |
CARBON MONOXIDE, COMPRESSED AIR MEDICAL G.M. | Praxair Canada Inc | 02014351 | Gas - Inhalation | 0.3 % | 12/31/1993 |
LUNG DIFFUSION TEST MIXTURE | matheson gas products canada inc. | 00580740 | Gas - Inhalation | .4 % | 12/31/1982 |
CO-HE-O2-N2 MIXTURE | 02154773 | Gas - Inhalation | 0.3 % | 12/31/1995 | |
LUNG DIFFUSION TEST MIXTURE | matheson gas products canada inc. | 00580767 | Gas - Inhalation | 1.5 % | 12/31/1982 |
LUNG DIFFUSION TEST MIX NO NE CO | Praxair Canada Inc | 00588075 | Gas - Inhalation | 0.3 % | 12/30/1970 |
CARBON MONOX, HELIUM, OXYGEN, NITROGEN L.D.M. | Praxair Canada Inc | 02014424 | Gas - Inhalation | 0.3 % | 12/31/1993 |
HOMEOPATHIC MEDICINE (S#498) DPS 30C | total health centre | 02079186 | Drops - Oral | 30 C / ML | 12/31/1994 |
LUNG DIFFUSION TEST MIXTURE GAS | Praxair Canada Inc | 00823066 | Gas - Inhalation | 0.1 % | 12/30/1970 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.